One possible explanation for the resistance to the standard chemotherapy would be a high expression of multidrug resistance (P-glycoprotein positive) phenotype in NK/T cell lymphoma patients. This evidence concerns the gene ABCB1 and T-cell non-Hodgkin lymphoma.